Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06005285 · ClinicalTrials.gov registry record · NA

Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism

A NA study of Autism, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT06005285: Recruiting NA study of Autism, sponsored by University of California, Davis.

NCT06005285 is a NA study of Autism that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 600 participants, above the 178-participant average among 104 other Autism trials with a reported enrollment target (237% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06005285, a NA study of Autism, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

This study tests the effectiveness of the Early Start Denver Model (ESDM) in community agencies that serve young autistic children. The feasibility, usability and acceptability of the model will be explored. Understanding effectiveness of new evidence-based models will increase the quality of autism care available to more diverse children and families in more geographic locations.

Primary Outcome

the APPL operationalizes research-based language development stages. Language phases are derived from spoken language or augmentative communication systems and standardized assessments. Language samples will be obtained from transcriptions of child-caregiver interactions recorded at each timepoint and coded by naive observers

Conditions Studied

Interventions

  • BEHAVIORAL Early Start Denver Model (ESDM)
  • BEHAVIORAL Early Intensive Behavioral Intervention (EIBI)

Study Locations (1)

California

  • University of California, Davis MIND Institute - Sacramento

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2024-03-01
Est. Completion 2028-06-01
Phase NA
University of California, Davis

657 total trials

What NCT06005285 shows while recruiting

NCT06005285 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 178-participant average among 104 other Autism trials with a reported enrollment target (237% higher).

The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 2 interventions - of which Early Start Denver Model (ESDM) is the first listed.

NCT06005285 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06005285 about?

NCT06005285 is a clinical study titled "Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism". This study tests the effectiveness of the Early Start Denver Model (ESDM) in community agencies that serve young autistic children. The feasibility, usability and acceptability of the model will be explored. Understanding effectiveness of new evidence-based models will increase the quality of autism...

What is the current status of trial NCT06005285?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-03-01. Estimated completion is 2028-06-01.

What conditions does trial NCT06005285 study?

This clinical trial studies the following conditions: Autism.

What interventions are being tested in trial NCT06005285?

The interventions under investigation include: Early Start Denver Model (ESDM) (BEHAVIORAL), Early Intensive Behavioral Intervention (EIBI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06005285?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06005285 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06005285's enrollment target sits among peer trials

600 4th of 104 higher than 101 of 104 other Autism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06005285, the US trial registry maintained by the National Library of Medicine. NCT06005285 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.